NEWS
Our Latest News
ARCHIMED Diagnostics closes its acquisition of ARK Diagnostics, a global leader in disease and drug monitoring & detection
The previous majority owner, listed South Korean specialty chemicals company, Soulbrain Holdings, retains a significant minority stake in California-based ARK.
ARCHIMED Diagnostics closes its acquisition of ARK Diagnostics
October
28,
2025
ARCHIMED’s FIM Medical becomes the leading developer and distributor of European occupational healthcare devices with its purchase of Vistec GmbH
October
23,
2025
ARCHIMED buys Premium Global Dental Healthcare US Company ZimVie
October
20,
2025
ARCHIMED buys Denmark’s DermaPharm A/S, a leading developer and manufacturer of skincare products
October
15,
2025
368